drugset / Trial / NCT06973681
A Study of BGM0504 Evaluating Weight Loss in Overweight or Obese Chinese Subjects
RandomizedParallel-groupDouble-blindTreatment
Summary
To assess the effect of BGM0504 injection versus placebo on weight loss in overweight or obese subjects after 24 weeks of treatment.
Timeline
- Start
- 2023-10-13
- Primary completion
- 2024-09-13
- Completion
- 2024-09-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BGM0504 | Unknown | 5 mg | Subcutaneous |
| Subject | BGM0504 | Unknown | 10 mg | Subcutaneous |
| Subject | BGM0504 | Unknown | 15 mg | Subcutaneous |